📈 Premium International Injectable Advances Domestic Pharma Manufacturing

Premium International Injectable (Pvt) Ltd is progressing the construction of its modern facility within a Board of Investment (BOI) zone to bolster local medicine production. • Core Scope & Operations • Specialized focus on biotechnology-based insulin and generic Small Volume Parenteral (SVP) injectable medicines. • Plant built to European standards, aiming for EU GMP certification to enable future export opportunities. • Broadens industrial capabilities and strengthens national healthcare supply chain resilience. • Public-Private Collaboration • Hon. Minister of Health Dr. Nalinda Jayatissa reviewed the development alongside company leadership. • Active engagement with the State Pharmaceuticals Manufacturing Corporation (SPMC) and industry stakeholders to address local demand. • Strategic Outlook • Designed as a baseline for long-term growth, with plans to expand formulations, dosages, and strengths as market demands evolve. • Open to strategic partners, investors, and suppliers to support future expansion in pharmaceutical manufacturing.